San Diego-based DexCom Inc. (Nasdaq: DXCM) and Asante Solutions Inc., manufacturer of the Asante Snap Insulin Pump, announced Thursday their intention to enable the Dexcom mobile app platform, which is currently under development, to integrate and display insulin data from the Asante Snap Insulin Pump.
This will be the second insulin delivery device to be integrated into the Dexcom mobile app, which is designed to aggregate glucose and other diabetes-related data from patients’ devices and display the integrated data on a smartphone.
In June, Dexcom announced its intention to maintain an “open architecture” approach to diabetes-related data that will include an “Authorized by Dexcom” mark to indicate the compatibility of devices and apps integrating Dexcom CGM data.
